Ali Fattaey
Chief Executive Officer at Metabomed Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Dentzer | M | 57 | 8 years | |
| Eyal Gottlieb | M | - |
Metabomed Ltd.
 Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | 11 years |
| David Aviezer | M | 59 |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | - |
| Jon M. Wefald | M | 86 |
Kansas State University
| 38 years |
| Pini Orbach | M | - |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | - |
| Ohad Hammer | M | - |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | - |
| Noga Yerushalmi | F | - |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | - |
| Denis Patrick | M | - |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | - |
| Johannes Zanzinger | M | - |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | - |
| Daguang Wang | M | - |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Passeri | M | 63 | 16 years | |
| William Steinkrauss | M | 39 | 6 years | |
| Michael Gray | M | 53 | 16 years | |
| Wolf-Dieter Busse | M | - |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | - |
| Lori Kunkel | M | 66 |
ACT Biotech, Inc.
ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | 8 years |
| James McNab | M | 80 | 17 years | |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 years |
| Mani Mohindru | M | 52 | 4 years | |
| Azfar Moazzam | M | - |
Kansas State University
| 4 years |
| Kenneth J. Pienta | M | 64 | 4 years | |
| Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 years |
| David Tuck | M | 72 | 3 years | |
| Ramiro Jordan | M | - |
Kansas State University
| 4 years |
| Marilyn E. Wortzman | F | 77 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 9 years |
| Susan B. Bayh | F | 64 | 13 years | |
| Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 years |
| James Tobin | M | 79 | 20 years | |
| Francis McCormick | M | 73 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Kevin Kickhaefer | M | - |
Kansas State University
| 4 years |
| Scott Stewart | M | - |
Kansas State University
| 4 years |
| Joseph B. Freeman | M | - |
Kansas State University
| 1 years |
| Jeff J. Ronning | M | - |
Kansas State University
| 4 years |
| Scott D. Claassen | M | - |
Kansas State University
| 4 years |
| Sheila J. Hayter | F | - |
Kansas State University
| 4 years |
| Daniel K. Perrier | M | - |
Kansas State University
| 5 years |
| Christian Khorigin | M | 67 |
Kansas State University
| 2 years |
| Scott Oppliger | M | - |
Kansas State University
| 4 years |
| Gary Skrdlant | M | - |
Kansas State University
| 2 years |
| Brian M. Quinn | M | - |
Kansas State University
| 4 years |
| Inci Dannenberg | M | - |
Kansas State University
| 2 years |
| Allan Gardner | M | - |
Kansas State University
| 4 years |
| Todd R. Stonebraker | M | - |
Kansas State University
| 4 years |
| Radka Doehring | M | 58 |
Kansas State University
| 4 years |
| Bo Purtic | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Leona Saunders | M | - | - | |
| Rich Mike | M | - |
Kansas State University
| 4 years |
| Jon D. Srna | M | - |
Kansas State University
| 4 years |
| Dewey Rushing | M | - |
Kansas State University
| - |
| Mike McKnight | M | 57 |
Kansas State University
| 3 years |
| Daniel Wicker | M | 53 |
Kansas State University
| 4 years |
| Lisa Massmanian | F | - | - | |
| Simone Botti | M | - |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | 7 years |
| Lois Cox | F | - |
Kansas State University
| 4 years |
| Kim Savage | F | - |
Kansas State University
| 4 years |
| Tania Chander | M | - | - | |
| Jaye Viner | M | 67 | 3 years | |
| Gary Spencer | M | - |
Kansas State University
| 4 years |
| Choong Wai Wong | M | 59 |
Kansas State University
| 4 years |
| Debi Rogers | M | - |
Kansas State University
| 3 years |
| Nancy Atwater | F | - |
Kansas State University
| 4 years |
| Martin Giedlin | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Scott Mills | M | - |
Kansas State University
| 4 years |
| Tin Yue Ting | M | 69 |
Kansas State University
| - |
| William G. Gerber | M | 77 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| David P. Ginther | M | - |
Kansas State University
| 4 years |
| Vijai P. Mohan | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Clay Eric Brethour | M | - |
Kansas State University
| 3 years |
| David Dykstra | M | 60 |
Kansas State University
| 4 years |
| Walter Moos | M | 69 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Gregory J. Giotta | M | 77 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Nicole Vitullo | F | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 7 years |
| Brad K. Brenneman | M | - |
Kansas State University
| 4 years |
| George Scangos | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 years |
| Maurizio Voi | M | - | 2 years | |
| Bill Mock | M | - |
Kansas State University
| 4 years |
| Rodolfo Ploder | M | 63 |
Kansas State University
| 2 years |
| David G. Ichikawa | M | 71 |
Sagres Discovery, Inc.
 Sagres Discovery, Inc. Pharmaceuticals: MajorHealth Technology Sagres Discovery, Inc. researches and discovers oncology treatments. Its technology platform combines the biology of cancer formation in mouse models with the robustness of genomic technologies to enable discovery and clinical validation of human cancer genes. The company is headquartered in Davis, CA. | 2 years |
| Scott M. Freeman | M | 67 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 years |
| Ody Maningat | M | 69 |
Kansas State University
| 3 years |
| Chace Brundige | M | - |
Kansas State University
| 4 years |
| Damon Hininger | M | 54 |
Kansas State University
| 4 years |
| Kerry Winter | M | - |
Kansas State University
| 4 years |
| Kevin K. Elmore | M | - |
Kansas State University
| 4 years |
| Abdul Rachman | M | 69 |
Kansas State University
| 2 years |
| Jerri Christensen | F | - |
Kansas State University
| 4 years |
| Kurt T. Grier | M | - |
Kansas State University
| 4 years |
| Mark Eugene Luetters | M | - |
Kansas State University
| 4 years |
| Bert Frost | M | 59 |
Kansas State University
| 4 years |
| Jerome I. Nadel | M | - |
Kansas State University
| 1 years |
| Eric Scheele | M | - |
Kansas State University
| 4 years |
| Steven Packebush | M | 59 |
Kansas State University
| 4 years |
| Chris Pravecek | M | - |
Kansas State University
| 2 years |
| Lee Handke | M | - |
Kansas State University
| 4 years |
| Robert Jacks | M | - |
ACT Biotech, Inc.
ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | - |
| Sheridan Swords | M | 55 |
Kansas State University
| 4 years |
| Jeffrey L. Swearingen | M | - |
Kansas State University
| 4 years |
| Charles Morrison | M | 55 |
Kansas State University
| 4 years |
| Jeff Bissey | M | - |
Kansas State University
| 4 years |
| Nick Hatcher | M | 60 |
Kansas State University
| 4 years |
| Chuck Warta | M | - |
Kansas State University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 91 | 91.00% |
| Israel | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ali Fattaey
- Personal Network
